论文信息 - Phase 1 Study of CA-4948, a Novel Inhibitor of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in Patients with R/R Non-Hodgkin Lymphoma (NHL) - 字舞流文

Phase 1 Study of CA-4948, a Novel Inhibitor of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in Patients with R/R Non-Hodgkin Lymphoma (NHL)

H. Tun | A. Younes | R. Martell | M. Lunning | I. Isufi | L. Leslie | A. Rosenthal | K. Patel | G. Nowakowski